A trial for evaluation of effectiveness and safety for dose reduction DTP-IPV vaccination in adult
Phase 4
- Conditions
- healthy adult
- Registration Number
- JPRN-UMIN000022793
- Lead Sponsor
- Tokyo Metropolitan Children's Medical Center
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 80
Inclusion Criteria
Not provided
Exclusion Criteria
1. inoculated pertussis vaccine for adulthood 2. past history for pertussis infection 3. chronic kidney disease 4. immunodeficiency 5. using immunosuppresant or oral steroid 6. past history for anaphyraxis by vaccines 7. Judged inappropriate for this study by the physicians
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method pertussis antibody titer after vaccination
- Secondary Outcome Measures
Name Time Method